Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

589
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
589
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

172
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
172
Liver Physiology01:30

Liver Physiology

593
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
593

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the timing of eukaryotic origin.

Biological reviews of the Cambridge Philosophical Society·2026
Same author

From Iron to Depression: The Crosstalk Between the Periphery and Brain.

Neuroscience bulletin·2026
Same author

MOF-Stabilized Pd Nanosheets With Exposed Active Crystal Planes for Efficient Hydrogen Evolution.

ChemSusChem·2026
Same author

Overall Water-Splitting Enabled by Bifunctional NiPd/Pd Heterodimer Fabricated via In Situ Etching-Growth Route.

Inorganic chemistry·2026
Same author

Molecular Interfacial Engineering of Lithiophilic Protection Layer Realizing 600 Wh kg<sup>-1</sup> Anode-Free Lithium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Correction: Analysis of proton pump inhibitor-associated drug problems and contributing factors among hospitalized nephrology patients.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Jul 14, 2025

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.6K

Liver Iron Overload Drives COVID-19 Mortality: a Two-Sample Mendelian Randomization Study.

Huimin Tian1, Xiangjie Kong2, Fulei Han2

  • 1Zhonglou District Center for Disease Control and Prevention, Changzhou, Jiangsu, China. tianhuimin78@163.com.

Biological Trace Element Research
|October 9, 2023
PubMed
Summary

High liver iron levels increase COVID-19 mortality risk. Maintaining normal iron levels may reduce deaths from the virus, suggesting iron overload is an independent risk factor.

Keywords:
COVID-19Iron overloadMendelian randomization analysisMortalitySeverity

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

846
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K

Related Experiment Videos

Last Updated: Jul 14, 2025

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

846
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.0K

Area of Science:

  • Genetics
  • Epidemiology
  • Internal Medicine

Background:

  • Observational studies link iron overload to increased COVID-19 severity and mortality.
  • Causal relationship between iron overload and COVID-19 outcomes remains uncertain.

Purpose of the Study:

  • To investigate the causal association between genetic liability to iron overload and COVID-19 severity and mortality using Mendelian randomization.
  • To determine if iron accumulation is an independent risk factor for COVID-19 mortality.

Main Methods:

  • Two-sample Mendelian randomization (MR) analysis.
  • Utilized genome-wide association study data for liver iron and ferritin levels as exposures.
  • Employed COVID-19 hospitalization and mortality data as outcomes.
  • Inverse-variance weighted (IVW) method for primary analysis, with sensitivity analyses for robustness.

Main Results:

  • Genetically predicted high liver iron levels were significantly associated with increased COVID-19 mortality (OR=1.38, P=0.02).
  • Sensitivity analyses confirmed the robustness of the association.
  • A non-significant trend towards increased COVID-19 hospitalization risk was observed with high liver iron levels.

Conclusions:

  • COVID-19 mortality may be partly attributed to hepatic iron accumulation.
  • Iron overload can be considered an independent risk factor for COVID-19 mortality.
  • Managing iron levels is a potential strategy to mitigate COVID-19 mortality.